Document Details

MGEN $0.95 $ + 0.10 (12.31%)
Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Miragen Therapeutics (Boulder, CO)
Event Date 11/7/2018
Filing Date 11/7/2018

Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.

File Section(s)

  1. FORM 8-K
  2. EXHIBIT 99.1

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.